Methods of use of cyclopamine analogs
AssigneeInfinity Pharmaceuticals, Inc.
InventorsAlfredo C. Castro, Michael J. Grogan, William Matsui, Karen J. McGovern, Martin R. Tremblay
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula:
Claims92
A method for treating a cancer in a mammal, comprising administering to the mammal a compound selected from:
- or a pharmaceutically acceptable salt thereof, in combination with one or more other cancer treatments;
- wherein the cancer is chosen from one or more of:
- a cancer of the pulmonary system, a brain cancer, a cancer of the gastrointestinal tract, a skin cancer, a genitourinary cancer, a pancreatic cancer, a lung cancer, a medullobastoma, a basal cell carcinoma, a glioma, a breast cancer, a prostate cancer, a testicular cancer, an esophageal cancer, a hepatocellular cancer, a gastric cancer, a gastrointestinal stromal tumor (GIST), a colon cancer, a colorectal cancer, an ovarian cancer, a melanoma, a neuroectodermal tumor, head and neck cancer, polycythemia Vera, Waldenstrom's macroglobulinemia, heavy chain disease, essential thrombocythemia, a sarcoma, a soft-tissue sarcoma, fibrosarcoma, myxosarcoma, liposarcoma, a chondrosarcoma, an osteogenic sarcoma, a chordoma, an angiosarcoma, an endotheliosarcoma, a lymphangiosarcoma, a lymphangioendotheliosarcoma, a synovioma, a mesothelioma, a leiomyosarcoma, a cervical cancer, a uterine cancer, an endometrial cancer, a carcinoma, a bladder carcinoma, an epithelial carcinoma, a squamous cell carcinoma, an adenocarcinoma, a bronchogenic carcinoma, a renal cell carcinoma, a hepatoma, a bile duct carcinoma, a neuroendocrine cancer, or a carcinoid tumor.
A method for treating cancer, which comprises administering to a patient in need thereof a therapeutically effective amount of a compound of the formula:
- or a pharmaceutically acceptable salt thereof in combination with one or more other cancer treatments;
- wherein the cancer is chosen from one or more of:
- a cancer of the pulmonary system, a brain cancer, a cancer of the gastrointestinal tract, a skin cancer, a genitourinary cancer, a pancreatic cancer, a lung cancer, a medullobastoma, a basal cell carcinoma, a glioma, a breast cancer, a prostate cancer, a testicular cancer, an esophageal cancer, a hepatocellular cancer, a gastric cancer, a gastrointestinal stromal tumor (GIST), a colon cancer, a colorectal cancer, an ovarian cancer, a melanoma, a neuroectodermal tumor, head and neck cancer, polycythemia Vera, Waldenstrom's macroglobulinemia, heavy chain disease, essential thrombocythemia, a sarcoma, a soft-tissue sarcoma, fibrosarcoma, myxosarcoma, liposarcoma, a chondrosarcoma, an osteogenic sarcoma, a chordoma, an angiosarcoma, an endotheliosarcoma, a lymphangiosarcoma, a lymphangioendotheliosarcoma, a synovioma, a mesothelioma, a leiomyosarcoma, a cervical cancer, a uterine cancer, an endometrial cancer, a carcinoma, a bladder carcinoma, an epithelial carcinoma, a squamous cell carcinoma, an adenocarcinoma, a bronchogenic carcinoma, a renal cell carcinoma, a hepatoma, a bile duct carcinoma, a neuroendocrine cancer, or a carcinoid tumor.
A method for treating pancreatic cancer, which comprises administering to a patient in need thereof a therapeutically effective amount of a compound of the formula:
- or a pharmaceutically acceptable salt thereof in combination with gemcitabine.
Dependencies are inferred from the claim text.